Targeting complement C3a receptor resolves mitochondrial hyperfusion and subretinal microglial activation in

Insights

Progranulin (GRN) loss causes frontotemporal dementia by damaging retinal cells. This study reveals GRN impacts mitochondrial health and inflammation, offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Ophthalmology

Background:

  • Mutations in progranulin (GRN) cause frontotemporal dementia (FTD) linked to protein deficiency.
  • GRN-FTD involves diverse pathologies like lysosome dysfunction, microgliosis, and neuroinflammation, but the exact disease mechanism is unclear.

Purpose of the Study:

  • To investigate the role of progranulin in retinal integrity and its connection to frontotemporal dementia.
  • To elucidate the molecular mechanisms underlying progranulin deficiency-induced retinal dysfunction and neuroinflammation.

Main Methods:

  • Non-invasive retinal imaging in GRN-FTD patients and Grn knockout mice.
  • Super-resolution live imaging and transcriptomic analysis of retinal pigment epithelium (RPE) mitochondria.
  • Investigated the role of mitochondrial fission protein 1 (MTFP1) and complement signaling (C3aR).

Main Results:

  • Retinal imaging revealed photoreceptor and RPE deficits in GRN-FTD patients correlating with cognitive decline.
  • Grn mice showed early RPE dysfunction, microglial activation, and photoreceptor loss.
  • Loss of MTFP1 in Grn RPE led to mitochondrial hyperfusion, bioenergetic defects, and NF-kB-mediated C3aR activation, driving inflammation.

Conclusions:

  • Progranulin deficiency disrupts RPE mitochondrial integrity via MTFP1, initiating a cascade of inflammation.
  • Complement C3a-C3a receptor signaling exacerbates mitochondrial dysfunction and retinal inflammation.
  • Targeting C3aR antagonism can restore mitochondrial function and reduce neuroinflammation in GRN-FTD.

Related Concept Videos